Drug Shortage Report for ZARONTIN
Report ID | 172389 |
Drug Identification Number | 00022799 |
Brand name | ZARONTIN CAP 250MG |
Common or Proper name | ZARONTIN CAP |
Company Name | SEARCHLIGHT PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ETHOSUXIMIDE |
Strength(s) | 250MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | BOTTLE 100'S |
ATC code | N03AD |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-10-06 |
Actual start date | 2022-10-07 |
Estimated end date | 2023-02-15 |
Actual end date | 2023-02-01 |
Shortage status | Resolved |
Updated date | 2023-02-02 |
Company comments | RESOLVED |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1600 RUE NOTRE DAME OUEST, SUITE 312 MONTREAL, QUEBEC CANADA H3J 1M1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v22 | 2023-02-02 | French | Compare |
v21 | 2023-02-02 | English | Compare |
v20 | 2023-02-02 | French | Compare |
v19 | 2023-02-02 | English | Compare |
v18 | 2023-02-02 | French | Compare |
v17 | 2023-02-02 | English | Compare |
v16 | 2023-01-27 | French | Compare |
v15 | 2023-01-27 | English | Compare |
v14 | 2023-01-13 | French | Compare |
v13 | 2023-01-13 | English | Compare |
v12 | 2022-12-21 | French | Compare |
v11 | 2022-12-21 | English | Compare |
v10 | 2022-12-19 | French | Compare |
v9 | 2022-12-19 | English | Compare |
v8 | 2022-12-05 | French | Compare |
v7 | 2022-12-05 | English | Compare |
v6 | 2022-11-21 | French | Compare |
v5 | 2022-11-21 | English | Compare |
v4 | 2022-10-28 | French | Compare |
v3 | 2022-10-28 | English | Compare |